Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt No Debt
REPR's Cash to Debt is ranked higher than
85% of the 308 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.60 vs. REPR: No Debt )
REPR' s 10-Year Cash to Debt Range
Min: 0.01   Max: No Debt
Current: No Debt

Equity to Asset 0.81
REPR's Equity to Asset is ranked higher than
89% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.61 vs. REPR: 0.81 )
REPR' s 10-Year Equity to Asset Range
Min: -0.85   Max: 0.86
Current: 0.81

-0.85
0.86
Interest Coverage 201.60
REPR's Interest Coverage is ranked higher than
80% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 26.96 vs. REPR: 201.60 )
REPR' s 10-Year Interest Coverage Range
Min: 0.97   Max: 201.6
Current: 201.6

0.97
201.6
F-Score: 5
Z-Score: 7.91
M-Score: -2.16
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating margin (%) 11.59
REPR's Operating margin (%) is ranked higher than
79% of the 295 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.30 vs. REPR: 11.59 )
REPR' s 10-Year Operating margin (%) Range
Min: -23.01   Max: 24.28
Current: 11.59

-23.01
24.28
Net-margin (%) 8.08
REPR's Net-margin (%) is ranked higher than
76% of the 295 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.08 vs. REPR: 8.08 )
REPR' s 10-Year Net-margin (%) Range
Min: -25.71   Max: 29.98
Current: 8.08

-25.71
29.98
ROE (%) 13.54
REPR's ROE (%) is ranked higher than
86% of the 292 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.68 vs. REPR: 13.54 )
REPR' s 10-Year ROE (%) Range
Min: -439.34   Max: 146.24
Current: 13.54

-439.34
146.24
ROA (%) 11.32
REPR's ROA (%) is ranked higher than
92% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.50 vs. REPR: 11.32 )
REPR' s 10-Year ROA (%) Range
Min: -40.92   Max: 44.63
Current: 11.32

-40.92
44.63
ROC (Joel Greenblatt) (%) 35.05
REPR's ROC (Joel Greenblatt) (%) is ranked higher than
86% of the 298 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 24.70 vs. REPR: 35.05 )
REPR' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -95.99   Max: 69.55
Current: 35.05

-95.99
69.55
Revenue Growth (%) 22.70
REPR's Revenue Growth (%) is ranked higher than
94% of the 276 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.70 vs. REPR: 22.70 )
REPR' s 10-Year Revenue Growth (%) Range
Min: -12.6   Max: 26
Current: 22.7

-12.6
26
EBITDA Growth (%) -9.10
REPR's EBITDA Growth (%) is ranked higher than
59% of the 230 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.70 vs. REPR: -9.10 )
REPR' s 10-Year EBITDA Growth (%) Range
Min: 0   Max: 58.7
Current: -9.1

0
58.7
» REPR's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with REPR



No Insider Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 27.00
REPR's P/E(ttm) is ranked higher than
78% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 34.10 vs. REPR: 27.00 )
REPR' s 10-Year P/E(ttm) Range
Min: 2.45   Max: 34.44
Current: 27

2.45
34.44
P/B 1.70
REPR's P/B is ranked higher than
83% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.03 vs. REPR: 1.70 )
REPR' s 10-Year P/B Range
Min: 1.04   Max: 28.8
Current: 1.7

1.04
28.8
P/S 1.02
REPR's P/S is ranked higher than
89% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.91 vs. REPR: 1.02 )
REPR' s 10-Year P/S Range
Min: 0.42   Max: 3.67
Current: 1.02

0.42
3.67
EV-to-EBIT 6.76
REPR's EV-to-EBIT is ranked higher than
97% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 22.61 vs. REPR: 6.76 )
REPR' s 10-Year EV-to-EBIT Range
Min: 2.8   Max: 2673
Current: 6.76

2.8
2673
PEG 5.00
REPR's PEG is ranked higher than
81% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 121.00 vs. REPR: 5.00 )
REPR' s 10-Year PEG Range
Min: 1.02   Max: 5.2
Current: 5

1.02
5.2
Shiller P/E 5.80
REPR's Shiller P/E is ranked higher than
99% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. REPR: 5.80 )
REPR' s 10-Year Shiller P/E Range
Min: 3.9   Max: 40.4
Current: 5.8

3.9
40.4
Current Ratio 5.40
REPR's Current Ratio is ranked higher than
89% of the 302 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.77 vs. REPR: 5.40 )
REPR' s 10-Year Current Ratio Range
Min: 0.71   Max: 9.6
Current: 5.4

0.71
9.6
Quick Ratio 4.42
REPR's Quick Ratio is ranked higher than
89% of the 302 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.93 vs. REPR: 4.42 )
REPR' s 10-Year Quick Ratio Range
Min: 0.19   Max: 7.47
Current: 4.42

0.19
7.47

Valuation & Return

vs
industry
vs
history
Price/Net Cash 6.80
REPR's Price/Net Cash is ranked higher than
94% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. REPR: 6.80 )
REPR' s 10-Year Price/Net Cash Range
Min: 5.13   Max: 18
Current: 6.8

5.13
18
Price/Net Current Asset Value 3.40
REPR's Price/Net Current Asset Value is ranked higher than
95% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. REPR: 3.40 )
REPR' s 10-Year Price/Net Current Asset Value Range
Min: 2.33   Max: 19
Current: 3.4

2.33
19
Price/Tangible Book 1.90
REPR's Price/Tangible Book is ranked higher than
89% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.62 vs. REPR: 1.90 )
REPR' s 10-Year Price/Tangible Book Range
Min: 1.5   Max: 15
Current: 1.9

1.5
15
Price/DCF (Projected) 0.90
REPR's Price/DCF (Projected) is ranked higher than
97% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.59 vs. REPR: 0.90 )
REPR' s 10-Year Price/DCF (Projected) Range
Min: 0.68   Max: 8.7
Current: 0.9

0.68
8.7
Price/Median PS Value 0.80
REPR's Price/Median PS Value is ranked higher than
87% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.12 vs. REPR: 0.80 )
REPR' s 10-Year Price/Median PS Value Range
Min: 0.3   Max: 2.5
Current: 0.8

0.3
2.5
Price/Graham Number 1.00
REPR's Price/Graham Number is ranked higher than
93% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.49 vs. REPR: 1.00 )
REPR' s 10-Year Price/Graham Number Range
Min: 0.67   Max: 6.75
Current: 1

0.67
6.75
Earnings Yield (Greenblatt) 15.20
REPR's Earnings Yield (Greenblatt) is ranked higher than
92% of the 252 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.30 vs. REPR: 15.20 )
REPR' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.1   Max: 35.3
Current: 15.2

0.1
35.3
Forward Rate of Return (Yacktman) 17.62
REPR's Forward Rate of Return (Yacktman) is ranked higher than
90% of the 257 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.95 vs. REPR: 17.62 )
REPR' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -1   Max: 31.2
Current: 17.62

-1
31.2

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Repro-Med Systems, Inc was incorporated in the State of New York in March of 1980. The Company designs, manufactures and markets proprietary medical devices mainly for emergency medical applications and ambulatory infusion therapy. These products are regulated by the FDA. Its development and marketing focus are concentrated on the RES-Q-VAC(R) and the FREEDOM60(R) products. The FREEDOM60 uses an innovative 'engine' to create a constant pressure drive system. FREEDOM60(R) uses rate-controlled tubing with standard slide clamp and luer-lock connector on the patient end. Proprietary technology Employed in the FREEDOM60 uses constant pressure to administer drugs. FREEDOM60 avoids an important problem faced by electronic pumps currently on the market which Employ constant flow mechanisms that result in potentially dangerous, high pressures placed on indwelling catheters or under the skin. The Freedom60 Syringe Infusion Pump is designed for ambulatory medication infusions. The Company also designed and manufactured the Freedom60-FM, an enhanced version of the Freedom60 which contains an electronic flow monitor system that provides occlusion and end of infusion alarm. The Freedom60 use for Primary Immune Deficiency by injecting immune globulin under the skin as a subcutaneous administration continued to increase usage during the past year. This method has provided patients with improved quality of life with much fewer unpleasant side effects over the traditional intravenous route. The RES-Q-VAC(R) Emergency Airway Suction System is a lightweight, portable, hand-operated suction device that removes fluids from a patient's airway by attaching the RES-Q-VAC(R) pump to various proprietary sterile and non-sterile single-use catheters sized for adult and pediatric suctioning. The Company has introduced new, updated features including the FSP filter, new pediatric connectors, new graduated canister, new adult catheters, and new convenient carry pouch. It is also available with a flexible, portable LED white light source, which is attached to the top of the canister system and provides illumination for the medical professional during nighttime or low light conditions. The Company offers its products directly to large national accounts and emergency medical device distributors, as well as to regional distributors in the hospital respiratory care market.

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide